INTRODUCTION
Osteoarthritis of the hip leads to chronic pain that generates functional disability. Its incidence is estimated to be 500,000 new cases per year in the Caucasian American population. 1 The goal of the treatment of osteoarthritis of the hip is to reduce pain and improve function. Initially, the treatment is done conservatively, by changes in lifestyle, weight loss, physical therapy and drugs such as analgesics, non-steroidal anti-inflammatory drugs and chondroprotectors . However, in a number of cases, conservative treatments are not successful and there is a need of surgical treatment. Among established surgical treatments, the first method of choice is total hip arthroplasty, approximately 170,000 total hip arthroplasties being performed annually in US. 2 Hip arthroplasties were, at the beginning, all performed by the cemented technique. However, studies with long term follow-up evaluating cemented acetabular components showed rates of aseptic loosening of this component varying between 1% and 42%, tending to increase over time, especially after ten years of surgery. 3, 4 These facts motivated the emergence and development of uncemented acetabular components, which have been used in total hip arthroplasty for nearly two decades. An extensive published literature supports the use of uncemented implants, although the follow-up time in these papers is shorter than the case series with cemented prostheses. In a literature review, considering a uncemented implant, totalizing 2428 arthroplasties with a mean follow-up period of 7 years, the results obtained were 0.4% of loosening; 0.3% revision for aseptic loosening; 4.7% total reoperation; and 5% periacetabular osteolysis. 5, 6 When assessing the durability of femoral components, uncemented arthroplasties allow implant survival of 10 to 20 years, depending on the adequacy of form and materials developed in the course of technological medical advances. This time span is comparable to cemented femoral arthroplasties, with the additional advantage of greatly reducing the risk of intraoperative hemodynamic complications arising from the cementing process. [7] [8] [9] Despite the advances of uncemented prosthesis, there is still a discussion in the literature regarding the use of this model in patients with osteoarthritis from rheumatologic causes, mainly rheumatoid arthritis. 10, 11 However, there is consensus that the results of arthroplasty in these patients are worse. 12 The experience of our service is that uncemented implant can be used in such patients. 13 The objective of this study is to compare the osseointegration of the acetabular and femoral components , and acute complications of 196 patients operated of osteoarthritis of the hip due to rheumatic and non-rheumatic causes in our department.
CASES AND METHODS
Were evaluated, retrospectively, 196 patients through analysis of medical records and imaging tests. They underwent total hip arthroplasty with the same prosthesis type and same surgical technique used by the Hip Surgery Group, Instituto de Ortopedia e Traumatologia, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo in the period 2005-2009. These patients were divided into two groups according to the cause of hip osteoarthrosis: mechanical or rheumatic osteoarthrosis. As mechanical causes of osteoarthrosis of the hip the following conditions were considered: primary osteoarthrosis, osteonecrosis of the femoral head, sequela of development dysplasia of the hip, sequela of epifisiolistesis, Perthes sequela, sequelae to trauma and infection. The following conditions were considered rheumatologic causes of osteoarthritis of the hip: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus and psoriatic arthritis. Patients who underwent arthroplasty with prosthesis models other than patients with femoral neck fracture, and revision arthroplasties were not included. Were also excluded from the study patients who failed follow for any reason within one year. The present study is two-tailed, being our H0 null hypothesis equality of osseointegration of the arthroplasty components of both patient groups, and our alternative hypothesis H1 a difference between them. Surgical approaches used in surgery were the direct lateral approach (Hardinge) and the posterior approach. An uncemented acetabular component made of a porous titanium alloy coated with hydroxyapatite (MBA, Lépine ® ) was used. The used femoral component was the uncemented stem made of porous titanium alloy with hydroxyapatite (Targos, Lépine ® ) proximal cover. A polyethylene insert and a 28mm stainless steel modular femoral head were used. Infectious prophylaxis was achieved in all patients with cefuroxime 1.5 mg administered intravenously at induction of anesthesia, and repeated every 12h for 24h. Antithrombotic mechanical prophylaxis was done through motor and drug physiotherapy with subcutaneous enoxaparin 40mg per day for 30 days. After discharge patients were evaluated at 3 weeks, 6 weeks, 12 weeks, 6 months, 1 year, and annually thereafter. The analysis was made by reviewing medical records. Preoperative radiograph was used for the assessment of bone quality by Dorr et al.
14 classification. Radiographs of the immediate postoperative period and radiograph of the last postoperative follow up were evaluated by three independent senior surgeons for the presence of signs of occurrence of osseointegration and implant migration, suggesting its loosening. (Table 1 ) Acetabular osseointegration was considered through the presence of three of the five signs listed below, 15 in asymptomatic patients in the first year postoperatively evaluation, concomitant to the absence of radiographic signs of acetabular migration: The migration of the acetabular component was defined by the change in the abduction angle greater than 5° and change in the position of the implant in the horizontal or vertical axis, equal or greater than 3 mm, 16 considering as an horizontal parameter the bilacrimal line and as vertical parameter Kohler's line (Kohler's bisector tear). The evaluation of the femoral component is performed as described by Engh et al. 17 ( Table 2 ) 
RESULTS
Total hip arthroplasties were performed in 196 patients, and of these 31 had osteoarthrosis of the hip due to rheumatic diseases. The patients' overall mean age was 52.43 years old with standard deviation of 16.15 years old. The mean age of patients with osteoarthritis of the hip due to rheumatic diseases was 42.03 years old with a standard deviation of 13.46. In patients with hip mechanical disease, the mean age was 54.98 years old and standard deviation 14.18. The difference between both groups was statistically significant (P <0.05). Of the total sample 44.38% were women, among rheumatologic patients, 41.93 % were females and in the group of mechanical diseases, 44.84% belonged to this gender. There was no statistically significant difference between the two groups (p = 0.46) The disease had bilateral presentation in 25.51% of the sample group, and the occurrence of bilateralism was 38.7% among rheumatoid patients and 23.03% in the control group. This difference was not statistically significant (p = 0.06). The mean follow-up time of patients in the mechanical disorders group was 39 months with a standard deviation of 16.1 months. In the group of rheumatic diseases the mean follow-up was also 39 months, but with a standard deviation of 16.4 months. These data showed no statistical difference. Among the causes considered rheumatologic, fourteen patients had ankylosing spondylitis, twelve had rheumatoid arthritis, two had juvenile rheumatoid arthritis, two had psoriatic arthritis and two had systemic lupus erythematosus. (Figure 1 ) Among the mechanical causes, the distribution obtained showed 70 cases of primary osteoarthritis, 60 of osteonecrosis of the femoral head, nine posttraumatic, five post-infection, fifteen sequelae of developmental dysplasia of the hip five sequelae of Legg-Calvé-Perthes and one sequela to epifisiolistesis. (Figure 2 ) Bone quality presented in the total sample group observed was 37.24% Dorr A; 34.18% Dorr B; and 28.57% Dorr C. Among rheumatologic patients, none showed bone quality considered type A by the Dorr Classification system, 29.03% showed Dorr B and 70.96% Dorr C. Among the mechanical causes 44.24% were Dorr A, 35.15% Dorr B and 20.60% Dorr C. The difference between the distributions of bone quality between the groups was statistically significant, with p<0.05. (Figure 3 ) Regarding osseointegration of the acetabular component, there were four failures of osseointegration (2 % of the total), three in the group of mechanical disorders (1.8%) and one in the Figure 3 . Distribution according to bone quality (Dorr). Specifically noting the present sample, we have as main rheumatic cause ankylosing spondylitis, which is more common in younger men. Regarding the age of patients, it was also expected that rheumatic diseases would be mostly cured in younger patients than mechanical pathologies. However, the main cause in the group of mechanical pathologies is osteonecrosis of the femoral head, which unlike primary osteoarthritis, requires earlier surgical intervention. It has been noticed that the mean age of all patients was 52 years old, well below the usual mean age for hip arthroplastie. 18, 19 Patients in the group of rheumatic diseases showed worse bone quality, according to Dorr criteria, than the patients in the mechanical disorders group. This fact is well justified taking into account that the vast majority of rheumatic diseases present with osteopenia. Osteopenia is caused mainly by the use of corticosteroids, as well as by the patient's low demand, and metabolic changes due to the disease. Such changes do not occur so markedly in mechanical pathologies.
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No difference was observed regarding osseointegration of the implant components, either femoral or acetabular. We observed equivalent rates of need for revision and intraoperative fractures. This differs from the consensus that not cemented implants should not be used in patients with rheumatologic diseases, with the risk of major complications and premature failure of the implant. In our experience, patients with rheumatic diseases have similar outcome after uncemented hip arthroplasties, even with impaired bone quality and increased risk of infection (by the inherent immunosuppression of the disease and the use of immunosuppressive drugs to its control). Furthermore, the use of uncemented implants decreases almost totally the risk of hemodynamic complications, common during the cementing process, being a significant advantage. The survival rate of implants also showed no statistical difference between the groups (96.8% in the rheumatic diseases group, and 98.2% in the mechanical disorders group) and is comparable to the survival rates of implants reported in the literature, ranging from 97.5 to 100% in 10 years follow up. 20 Still, it is worth noting that in worldwide literature, infection cases are usually not included in the series, which did not occur in this study. If infection cases would have been excluded, the survival rate would have been even higher.
CONCLUSION
The result of this study suggests that there are no difference between the results obtained in uncemented total hip arthroplasty, among rheumatologic patients and not rheumatic, although this result is contrary to the consensus on the use of cemented hip prosthesis in patients with poor bone quality. In our experience, we observed a successful osseointegration of similar components in both groups, a similar prevalence of immediate and late complications, as well as the prosthesis survival. With these data, we suggest that more studies are performed to determine the equivalence of outcomes between the use and cemented and uncemented prostheses in rheumatologic patients, since no cementing represents a decrease of operative risks. The osseointegration of the femoral component, by the criteria already described, did not occur in only two patients, and all of them belonged to the group whose osteoarthritis was attributed to a mechanical factor (1.2% of the mechanical group, and 1% of the total). It is important to note that these two patients also showed lack of integration of the acetabular component. There was need for revision of the total hip arthroplasty in four patients with acetabular loosening. Three of these were part of the group of mechanical diseases and all of them had septic loosening of the prosthesis, two of them showed no femoral osseointegration (patients already mentioned in the previous paragraph) and a third patient with failure on acetabular osseointegration and fixed femoral. The patient group of rheumatic diseases, who required revision, had aseptic loosening of the acetabular component of the prosthesis, with fixed femoral component. With these data, we found that the survival rate of the implants in the rheumatic diseases group was 96.8% and in the group of mechanical disorders was 98.2%. There was no statistical difference (p > 0.05). (Table 3) Fourteen patients showed fractures during the surgical procedure, of these, eleven belonged to the group of mechanical causes and three to the rheumatic group. The percentage of fractures in the rheumatologic group was 9.67% and in the group of mechanical causes it was 6.66%. This difference was not significant (p > 0.05).
DISCUSSION
Both groups showed a similar distribution by gender, laterality and follow up time, showing that there was no sample selection bias. We observed, however, a lower mean age in the rheumatology group, a fact predicted by some authors with a trend to early surgical treatment in these patients. At first, it may be surprising that there was no statistical difference regarding the gender of the patients, since when speaking in rheumatologic diseases the main disease is rheumatoid arthritis, which is more common in younger women, and mechanical pathologies, which has as main disease primary osteoarthritis, more common in the elderly.
